Want to see AU:ILA full AI Analyst Report?
Total Valuation
Island Pharmaceuticals Ltd has a market cap or net worth of AU$116.96M. The enterprise value is AU$99.58.
Market CapAU$116.96M
Enterprise ValueAU$99.58
Share Statistics
Island Pharmaceuticals Ltd has 296,096,680 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding296,096,680
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Island Pharmaceuticals Ltd’s return on equity (ROE) is -0.73 and return on invested capital (ROIC) is -76.69%.
Return on Equity (ROE)-0.73
Return on Assets (ROA)-0.70
Return on Invested Capital (ROIC)-76.69%
Return on Capital Employed (ROCE)-0.79
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Island Pharmaceuticals Ltd is ―. Island Pharmaceuticals Ltd’s PEG ratio is -0.17.
PE Ratio―
PS Ratio0.00
PB Ratio7.63
Price to Fair Value7.63
Price to FCF-21.25
Price to Operating Cash Flow-22.65
PEG Ratio-0.17
Income Statement
In the last 12 months, Island Pharmaceuticals Ltd had revenue of 0.00 and earned -9.84M in profits. Earnings per share was -0.04.
Revenue0.00
Gross Profit-105.29K
Operating Income-10.62M
Pretax Income-10.13M
Net Income-9.84M
EBITDA-10.51M
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was -4.83M and capital expenditures -1.00, giving a free cash flow of -4.83M billion.
Operating Cash Flow-4.83M
Free Cash Flow-4.83M
Free Cash Flow per Share-0.02
Dividends & Yields
Island Pharmaceuticals Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.59
52-Week Price Change-10.98%
50-Day Moving Average0.43
200-Day Moving Average0.41
Relative Strength Index (RSI)30.35
Average Volume (3m)176.37K
Important Dates
Island Pharmaceuticals Ltd upcoming earnings date is Mar 3, 2027, TBA (Not Confirmed).
Last Earnings DateAug 26, 2026
Next Earnings DateMar 3, 2027
Ex-Dividend Date―
Financial Position
Island Pharmaceuticals Ltd as a current ratio of 24.62, with Debt / Equity ratio of 0.00%
Current Ratio24.62
Quick Ratio24.62
Debt to Market Cap0.00
Net Debt to EBITDA1.22
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Island Pharmaceuticals Ltd has paid -282.66K in taxes.
Income Tax-282.66K
Effective Tax Rate0.03
Enterprise Valuation
Island Pharmaceuticals Ltd EV to EBITDA ratio is -8.55, with an EV/FCF ratio of -18.59.
EV to Sales0.00
EV to EBITDA-8.55
EV to Free Cash Flow-18.59
EV to Operating Cash Flow-18.59
Balance Sheet
Island Pharmaceuticals Ltd has AU$12.87M in cash and marketable securities with AU$0.00 in debt, giving a net cash position of AU$12.87M billion.
Cash & Marketable SecuritiesAU$12.87M
Total DebtAU$0.00
Net CashAU$12.87M
Net Cash Per ShareAU$0.04
Tangible Book Value Per ShareAU$0.05
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Island Pharmaceuticals Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-59.29%